186 related articles for article (PubMed ID: 38028470)
1. Long-term cardiovascular mortality risk in patients with bladder cancer: a real-world retrospective study of 129,765 cases based on the SEER database.
Liao J; Zhou Z
Front Cardiovasc Med; 2023; 10():1142417. PubMed ID: 38028470
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Outcomes in the Patients With Colorectal Cancer: A Multi-Registry-Based Cohort Study of 197,699 Cases in the Real World.
Zhang S; Wang Y; Zhang P; Ai L; Liu T
Front Cardiovasc Med; 2022; 9():851833. PubMed ID: 35783821
[TBL] [Abstract][Full Text] [Related]
3. Competing risk nomogram for predicting cancer-specific mortality in patients with non-melanoma skin cancer.
Tang L; Zhang L; Zeng Y; Li Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8817-8827. PubMed ID: 37142808
[TBL] [Abstract][Full Text] [Related]
4. Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort.
Li Y; Chen T; Fu B; Luo Y; Chen L
Front Oncol; 2023; 13():1164401. PubMed ID: 37397381
[TBL] [Abstract][Full Text] [Related]
5. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME
Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813
[TBL] [Abstract][Full Text] [Related]
6. A novel risk prediction nomogram for early death in patients with resected synchronous multiple primary colorectal cancer based on the SEER database.
Zhang X; Zhao L; Hu Y; Deng K; Ren W
Int J Colorectal Dis; 2023 May; 38(1):130. PubMed ID: 37191907
[TBL] [Abstract][Full Text] [Related]
7. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
[TBL] [Abstract][Full Text] [Related]
8. Nomogram model for predicting cancer-specific mortality in patients with early-onset colorectal cancer: a competing risk analysis insight from the SEER database and an external validation cohort.
Fu X; Chen Y; Fan Z; Wang W; Wang Z; Yin H; Li J; Guo S
Transl Cancer Res; 2024 Apr; 13(4):1665-1684. PubMed ID: 38737689
[TBL] [Abstract][Full Text] [Related]
9. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Mortality of Patients with Initially Diagnosed Metastatic Cutaneous Melanoma.
Li W; Xiao Y; Xu X; Zhang Y
Ann Surg Oncol; 2021 Jul; 28(7):3490-3500. PubMed ID: 33191484
[TBL] [Abstract][Full Text] [Related]
10. Development of a prognostic nomogram for lymph node positive HR
Cheng X; Jiang J; Liang X; Zheng X
Gland Surg; 2023 Nov; 12(11):1541-1553. PubMed ID: 38107492
[TBL] [Abstract][Full Text] [Related]
11. Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study.
Li Z; Shi Y; Wu L; Zhang H; Xue J; Li W; Wang X; Zhang L; Wang Q; Duo L; Wang M; Wang G
Gland Surg; 2022 Dec; 11(12):1961-1975. PubMed ID: 36654948
[TBL] [Abstract][Full Text] [Related]
12. A novel nomogram for predicting long-term heart-disease specific survival among older female primary breast cancer patients that underwent chemotherapy: A real-world data retrospective cohort study.
Huang C; Ding Z; Li H; Zhou Z; Yu M
Front Public Health; 2022; 10():964609. PubMed ID: 36091523
[TBL] [Abstract][Full Text] [Related]
13. A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort.
Zhan G; Peng H; Zhou L; Jin L; Xie X; He Y; Wang X; Du Z; Cao P
Front Endocrinol (Lausanne); 2023; 14():1070396. PubMed ID: 36798659
[TBL] [Abstract][Full Text] [Related]
14. Competing risk analysis of cardiovascular mortality in multiple myeloma survivors.
Chen G; Guo H; Lin J; Luo S; Xu S
Transl Cancer Res; 2023 Dec; 12(12):3314-3326. PubMed ID: 38197077
[TBL] [Abstract][Full Text] [Related]
15. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
[TBL] [Abstract][Full Text] [Related]
16. Risk of cardiovascular death in patients with hepatocellular carcinoma based on the Fine-Gray model.
Zhang YL; Liu ZR; Liu Z; Bai Y; Chi H; Chen DP; Zhang YM; Cui ZL
World J Gastrointest Oncol; 2024 Mar; 16(3):844-856. PubMed ID: 38577452
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of nomogram for the cancer-specific mortality for HER2-positive breast cancer patients.
Wu N
Medicine (Baltimore); 2024 Mar; 103(11):e37330. PubMed ID: 38489717
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
Li S; Liu X; Chen X
BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
[TBL] [Abstract][Full Text] [Related]
19. Competing risk nomogram predicting cause-specific mortality in older patients with testicular germ cell tumors.
Wu X; Zhou M; Lyu J; Chen L
Front Med (Lausanne); 2024; 11():1327485. PubMed ID: 38695022
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
